Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, BioNTech SE ADR (NASDAQ: BNTX) closed at $108.97 up 0.44% from its previous closing price of $108.49. In other words, the price has increased by $0.44 from its previous closing price. On the day, 0.61 million shares were traded. BNTX stock price reached its highest trading level at $109.6 during the session, while it also had its lowest trading level at $108.0.
Ratios:
For a deeper understanding of BioNTech SE ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.02 and its Current Ratio is at 10.18. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 05, 2025, Reiterated its Buy rating but revised its target price to $145 from $134 previously.
On May 29, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $110.
On March 13, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $145.Citigroup initiated its Buy rating on March 13, 2025, with a $145 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 04 ’25 when Jeggle Helmut Wolfgang bought 150,000 shares for $113.10 per share.
ATHOS KG bought 175,000 shares of BNTX for $19,394,800 on Jun 02 ’25. On May 28 ’25, another insider, ATHOS KG, who serves as the 10% Owner of the company, bought 500,000 shares for $98.68 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNTX now has a Market Capitalization of 26195623936 and an Enterprise Value of 12378783744. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.83 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 4.507 whereas that against EBITDA is -12.137.
Stock Price History:
The Beta on a monthly basis for BNTX is 1.28, which has changed by 0.102935195 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, BNTX has reached a high of $131.49, while it has fallen to a 52-week low of $76.53. The 50-Day Moving Average of the stock is 9.63%, while the 200-Day Moving Average is calculated to be 0.51%.
Shares Statistics:
For the past three months, BNTX has traded an average of 1.23M shares per day and 1602530 over the past ten days. A total of 240.39M shares are outstanding, with a floating share count of 236.70M. Insiders hold about 1.54% of the company’s shares, while institutions hold 21.14% stake in the company. Shares short for BNTX as of 1747267200 were 5383345 with a Short Ratio of 4.37, compared to 1744675200 on 4340193. Therefore, it implies a Short% of Shares Outstanding of 5383345 and a Short% of Float of 5.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
